Detalles de la búsqueda
1.
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
J Am Soc Nephrol
; 35(3): 311-320, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261535
2.
Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial.
Nephrol Dial Transplant
; 37(7): 1302-1309, 2022 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34240198
3.
Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
BMC Nephrol
; 23(1): 82, 2022 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35216581
4.
Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.
Lancet
; 394(10196): 396-406, 2019 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248662
5.
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
Lancet
; 393(10179): 1417-1427, 2019 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30857647
Resultados
1 -
5
de 5
1
Próxima >
>>